A simple question
No.
Thanks to decades of research, screening and better treatment, some cancers are now often curable: about 90% of children with acute lymphoblastic leukaemia survive five years, and 99% with early testicular cancer (US data).1,2 None has been cured by AI. As of October 2026, no AI-discovered drug has full FDA approval for any disease.3,4
That's roughly 100×. The red line is not a rendering error.
A running log of the most powerful technology of our time, applied with great care to the wrong problems. Every entry is sourced. Newest first.
Tesla and SpaceX (Elon Musk)
Tesla unveiled the long-delayed Roadster outside Waco, Texas, nine years after the 2017 prototype. Its top trims use SpaceX-developed cold-gas thrusters to leap, flip and land. No price; Musk says production starts in 2028.
Reservations of $50,000 (Performance) or $250,000 (Thrust); no price announced. Deposits were first taken in 2017.
Actual rocket science, pointed at last at a car park.
Sources: Electrek, TechCrunch, Electrek
Friend (Avi Schiffmann)
An always-listening AI companion necklace, relaunched with a speaker so it can talk back. It costs $249, up from $129, and remembering anything beyond 30 days requires a monthly subscription of about $10.
$249 per pendant. The company earlier spent $1.8M on the friend.com domain and over $1M on New York subway ads.
A friend who is always listening, now on a subscription plan.
Sources: Engadget, TechCrunch, 404 Media
BuzzFeed
At SXSW, BuzzFeed presented new consumer AI apps as a source of revenue, including BF Island, a group chat where users recreate meme trends with AI-edited photos.
The future of media: a group chat of AI-edited memes.
Source: TechCrunch
AI.com (Kris Marszalek)
Crypto.com CEO Kris Marszalek launched AI.com, a platform for building personal AI agents, with a 30-second ad during Super Bowl LX. The website crashed under the traffic.
About $70M, paid in crypto, reportedly spent on the AI.com domain
Seventy million dollars for two letters, and the website still fell over.
Moltbook (acquired by Meta)
A Reddit-style social network where only AI agents post, comment and upvote, while humans may watch. Meta bought it in March 2026 and moved its founders into Meta Superintelligence Labs.
Doomscrolling, now fully automated. Humans welcome to observe.
Sources: NBC News, The Decoder
A desk tube that projects a 5.5-inch animated AI avatar, running on xAI's Grok at launch, to chat, coach gamers and help with schedules. Razer took $20 reservations, with shipping planned for the second half of 2026.
$20 reservation deposit; final price not announced
Companionship, now sold by the tube. USB-C cable included.
Samsung
Samsung announced the first refrigerator with Google Gemini: built-in cameras identify the food inside and suggest recipes. At the CES 2026 demo, it could not see items in the door shelves or the freezer.
A large language model, at last confirming that you are out of milk.
Sources: Samsung (via AAP / PR Newswire), heise online
OpenAI
A TikTok-style social app where every video is AI-generated, including 'cameos' of users themselves. It hit the top of the US App Store; in March 2026 OpenAI said it would discontinue the app.
Disney agreed in Dec 2025 to invest $1B in OpenAI and license 200+ characters for Sora; it exited the deal after the shutdown.
Six months, one Disney deal, then: "We're saying goodbye to Sora."
Sources: Bloomberg Law, Engadget, ABC News
Meta
A short-form video feed in the Meta AI app made entirely of AI-generated clips, which users can create, remix and cross-post to Instagram and Facebook. Meta began testing it as a standalone app in February 2026.
Reels, minus the inconvenience of anything having happened.
Sources: TechCrunch, TechCrunch
Tesla opened a 24-hour retro diner and drive-in cinema with EV chargers in Hollywood. On opening day, an Optimus humanoid robot scooped popcorn into bags for guests and waved.
Humanoid robotics reaches its first commercial milestone: popcorn.
Sources: CNBC (via NBC Bay Area), ABC7 Los Angeles
Humane
A $699 screenless AI wearable pitched as a smartphone alternative. Humane sold its technology and most staff to HP and switched the pins off on 28 February 2025, ten days after the announcement.
Humane raised $230M; HP paid $116M for its technology and staff, not the Pin
The future of computing, with ten days' notice.
Sources: Fortune, The Decoder
This is not an anti-AI site. Pointed at the right problem, AI already helps. We would simply like a lot more of this.
Lund University (Sweden)
The first randomised trial of AI-supported mammography screening, with about 106,000 women, found 12% fewer interval cancers than standard double reading. Earlier results showed 29% more cancers detected and 44% less reading work.
Fewer cancers missed between screenings, with less radiologist time per woman screened.
Source: Lund University
Google DeepMind and Yale University
A 27B-parameter open model built on Gemma simulated over 4,000 drugs and flagged silmitasertib as a 'conditional enhancer' that can make tumour cells more visible to the immune system. Lab tests in human cell models confirmed it.
An AI-generated cancer hypothesis that held up in the lab. Early-stage, preprint only, but real science.
Source: The Decoder
Artera
The FDA granted De Novo authorisation to AI software that reads biopsy pathology images to estimate long-term outcomes, such as risk of metastasis, for patients with non-metastatic prostate cancer. Validated on data from phase 3 trials.
Helps decide who needs more aggressive treatment and who can be spared it.
Sources: Artera, Urology Times
University of Lübeck and Vara
A real-world study of 463,094 women screened at 12 German sites found AI-supported reading detected 6.7 breast cancers per 1,000 versus 5.7 without AI, 17.6% more, with no increase in recall rate.
More cancers found in routine screening, without more false alarms.
Google DeepMind (Demis Hassabis, John Jumper)
Half of the 2024 Chemistry Nobel went to the creators of AlphaFold2, which predicts protein structures. In one early use, AlphaFold structures helped find a new inhibitor candidate for a liver cancer target, CDK20.
Knowing a protein's shape is a starting point for designing drugs against it, cancer drugs included.
Sources: Science News, Chemical Science (via PMC)
The people deciding where AI goes read the same feeds you do.